AbbVie Revenue Rises on Immunology Growth

Date:




AbbVie posted higher fourth-quarter revenue on the back of growth from its immunology portfolio, led by arthritis and Crohn’s disease drugs Skyrizi and Rinvoq.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

The Best New Shows on TV and Streaming This Week

Another week means new series and new TV show...

Germany’s Merck KGaA Expects Currency Headwinds to Weigh on Earnings

The company anticipates currency headwinds would continue to weigh...

Unrivaled playoffs 2026: Schedule, teams, stats to know

For four quarters Wednesday, Kelsey Plum and Breanna Stewart...